Bio-Apartheid: How America’s Billionaires Are Buying the Future of Medicine OpenAI CEO Sam Altman, Amazon founder Jeff Bezos, Palantir co-founder Peter Thiel and hedge fund billionaire Bill Ackman are pouring fortunes into longevity research, cellular rejuvenation and experimental medicine. Their money is already shaping the research agenda—and putting them closest to the laboratories, companies and specialists behind the breakthroughs. Everyone else is left waiting for prices to fall and treatments to reach ordinary patients—if they ever do. 👉 Read our full investigation on Substack to learn how billionaire capital is reshaping the future of human biology.